Clinical Trials Directory

Trials / Unknown

UnknownNCT05730972

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Transcutaneous Electrical Acupoint Stimulation (TEAS) for the Treatment of Pain in Bone Metastases of Lung Cancer: A Multicenter Prospective RCT Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
188 (estimated)
Sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This multicenter, prospective, randomized controlled research study aims to objectively evaluate the role of transcutaneous electrical acupoint stimulation (TEAS), which combines the theory of acupuncture with transcutaneous electrical nerve stimulation (TENS) therapy, for the treatment of pain in patients with bone metastases from lung cancer.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous electrical acupoint stimulationThe patients are taken in the recumbent or sitting position, and the local skin at the acupoints is routinely disinfected. A pair of conductive gel patch, connecting to the Huatuo SDZ-ⅡB portable electronic needle therapy instrument, are respectively affixed to the ipsilateral acupoint group, so as contralateral side.
DEVICESham transcutaneous electrical acupoint stimulationThe electroacupuncture instrument has a normal screen display as the Huatuo SDZ-ⅡB portable electronic needle therapy instrument, but could not output current normally.
DRUGRoutine palliative treatmentThe patients in both groups received routine palliative treatment of tumors, such as chemotherapy, immunotherapy, targeted therapy, drug analgesic therapy, nutrition support, and so on.

Timeline

Start date
2023-12-15
Primary completion
2025-04-30
Completion
2025-12-31
First posted
2023-02-16
Last updated
2023-12-13

Source: ClinicalTrials.gov record NCT05730972. Inclusion in this directory is not an endorsement.